Opportunity
DIBBS #SPE2DP-26-T-3478
DLA Solicitation for Moxifloxacin Hydrochloride Tablets (400 mg) for Navy Vessel
Posted
May 20, 2026
Respond By
May 26, 2026
Identifier
SPE2DP-26-T-3478
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA is soliciting Moxifloxacin Hydrochloride tablets for delivery to a U.S. Navy vessel. - Government Buyer: - Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - OEMs (Approved Manufacturers): - TEVA Pharmaceuticals USA, Inc. - Rising Pharma Holdings, Inc. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - National Stock Number (NSN): 6505-01-503-4772 - TEVA Part Number: NDC00093-7387-56 - Rising Pharma Part Number: NDC57237-0156-30 - Quantity: 5 bottles - Notable Requirements: - Only TEVA Pharmaceuticals USA, Inc. and Rising Pharma Holdings, Inc. are approved sources - Product must comply with DLA packaging and medical marking standards - Shelf life requirement: 36 months (non-extendable) - Compliance with Buy American Act and hazardous material labeling - Delivery required within 20 days, FOB destination to USS MOBILE (LCS 26) Blue Air Department, FPO AP 96694
Description
MOXIFLOXACIN HYDROC (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7016833667) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.